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38Native T1 in Discrimination of Acute and
Convalescent Stages in Patients With
Clinical Diagnosis of Myocarditis
A Proposed Diagnostic Algorithm Using CMRABSTRACTOBJECTIVES This study investigated whether T1 mapping by cardiac magnetic resonance (CMR) reﬂects theclinical evolution of disease in myocarditis and supports its diagnosis independently of the disease stages.BACKGROUND Acute viral myocarditis is characterized by a range of intracellular changes due to viralreplication and extracellular spill of debris within days of viral infection. Convalescence may be characterized
by a chronic low-grade inﬂammation leading to ventricular remodelling, but also a complete resolution of
myocardial changes.METHODS Patientswith clinical diagnosis of viralmyocarditis (N¼ 165) underwent routine clinical CMRprotocol
(1.5- and 3.0-T) for assessment of cardiac function and structure, and tissue characterization with T2-weighted imaging
and late gadolinium enhancement. T1 mapping was obtained in amid-ventricular short-axis slice before and>20min after
administration of 0.2 mmol/kg of gadobutrol.RESULTS Compared with control subjects (n ¼ 40), T1 indexes were increased in patients with myocarditis.
Patients with acute symptoms (n ¼ 61) had higher values of T1 indexes compared with patients in clinical convalescence
(n ¼ 67). Native T1 is an independent discriminator between health and disease, as well as a discriminator between acute
and convalescent stage of the disease. Native T1- was superior to T2-weighted imaging and late gadolinium enhancement
with high diagnostic accuracy and positive and negative predictive values. Using pre-deﬁned cutoff values for normal
ranges, we demonstrated that acute myocarditis can be independently identiﬁed by native T1 of >5 SD above the mean of
normal range, whereas convalescence is best deﬁned by either abnormal native T1 (>2 SD) or presence of late gadolinium
enhancement. We prospectively tested a new diagnostic algorithm in an independent dataset of patients with clinical
diagnosis of myocarditis and achieved similar diagnostic performance.CONCLUSIONS Thenewdiagnostic algorithmusing native T1 can reliablydiscriminate betweenhealthanddiseaseand determine the clinical disease stage in patients with a clinical diagnosis of myocarditis. (J Am Coll Cardiol Img
2015;8:37–46) © 2015 by the American College of Cardiology Foundation.M yocarditis is an important cause of cardiacmorbidity and mortality (1–6). Character-ized by a wide spectrum of myocardial
changes and nonspeciﬁc clinical presentation, car-
diac disease can be challenging to detect, and
clinical management pathways can be uncertain.
Myocardial tissue changes include intracellular and
interstitial edema and inﬂammatory inﬁltration
within days of viral infection, followed by chronic
low-grade inﬂammation, myocardial remodeling,
and ﬁbrosis but also complete resolution, marking
the stages of acute disease and clinical convales-
cence, respectively (1,2). Whether accurate diagnosis
improves the clinical course or facilitates treatment
remains unclear.Tissue characterization by cardiac magnetic reso-
nance (CMR) is increasingly used when myocarditis is
suspected clinically. Current diagnostic recommen-
dations on the basis of Lake Louise criteria (LLC) rely
on a combination of T1-weighted (relative enhance-
ment ratio), T2-weighted imaging (edema ratio >1.9,
regional increase in T2 signal intensity [SI]), and late
gadolinium enhancement (LGE) imaging, whereby
the positive ﬁndings of 2 of 3 imaging techniques
conﬁrm the diagnosis (7). These recommendations
are on the basis of the concept that either the in-
ﬂammatory involvement of the myocardium (edema,
hyperemia, and capillary leakage) and/or myocardial
necrosis/replacement ﬁbrosis can be visualized and
a suspected diagnosis conﬁrmed (6–12) (Figure 1).
AB BR EV I A T I O N S
AND ACRONYM S
CMR = cardiac magnetic
resonance
LLC = Lake Louise criteria
LGE = late gadolinium
enhancement
SI = signal intensity
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39However, in the absence of positive ﬁndings, the LLC
do not allow a reliable exclusion of disease (7,9,13).
Furthermore, current means of differentiation
between acute and convalescent myocarditis rely on
detection of inﬂammatory components mainly by
increased T2 signal and evidence of normalization
after clinical resolution on a follow-up study (9,14–19).
Patients commonly undergo CMR imaging out-
side of their acute period and without an opportunity
for a serial follow-up. Recent evidence suggests that
novel approaches on the basis of T1 mapping pro-
vide an improved detection of myocardial edema in
acute myocarditis (20,21) and subclinical low-gradeFIGURE 1 Acute Myocarditis
Pink arrows indicate the presence of late gadolinium enhancement (LGE)
or increased T2 signal. Pericardial effusion (yellow arrows) in Patient #3.
ER ¼ edema ratio.
SEE PAGE 47myocardial inﬂammation (22) compared with con-
ventional T2 imaging and of diffuse myocardial
ﬁbrosis in ventricular remodeling (23) compared with
LGE. We examined whether myocardial T1 mapping
may potentially discriminate between health and
disease, as well as determine the stage of disease
(i.e., between acute myocardial inﬂammation and
convalescent disease).
METHODS
Consecutive patients presenting with a clinical diag-
nosis of viral myocarditis were recruited to this
study. Clinical diagnosis of viral myocarditis was
established in all cases by the presence of cardiac
symptoms in the course of a recent ﬂu-like illness,
documented electrocardiogram changes, rise in in-
ﬂammatory marker and/or troponin levels, and
exclusion of signiﬁcant coronary artery disease (4,5).
Characteristics were recorded for all patients,
including age, sex, body mass index, and presence of
traditional cardiovascular risk factors. Symptoms at
presentation, systolic/diastolic blood pressure, tro-
ponin leak, and C-reactive protein levels were
recorded. Endomyocardial biopsy was not routinely
used for conﬁrmation of disease (3,17,19). Patients
with various stages of disease presented for CMR
imaging; we classiﬁed the condition of those pre-
senting with active symptoms and increased levels of
serological markers early in the course of disease
(typically via inpatient CMR referrals, within a week
after the onset of symptoms) as acute myocarditis
(n ¼ 61). Patients who were no longer symptomatic
and had serological marker levels within the normal
range represented the group of convalescent
myocarditis (n ¼ 67; commonly as outpatient CMR
referrals from district peripheral hospitals). There
was no patient overlap between the 2 groups. An
additional 37 patients with the active symptomaticstage of disease underwent 2 serial CMR
scans and a follow-up study after clinical
resolution and served as a comparison cohort
for the studied groups of independent pa-
tients. An independent cohort of 52 patients
fulﬁlling the above inclusion criteria (acute
myocarditis, n ¼ 24; convalescent myocar-
ditis, n ¼ 28) were sourced from the Inter-
national T1 Multicentre CMR Study for
prospective validation of the diagnostic algorithm
(King’s College London, United Kingdom, n ¼ 23; St.
Vincent’s University Hospital, Sydney, Australia,
n ¼ 29). Forty healthy subjects with no clinical or
serological evidence of systemic inﬂammation or
permanent use of anti-inﬂammatory medication
(e.g., aspirin, nonsteroidal anti-inﬂammatory drugs,
corticosteroids, antihistamines) and normal ﬁndings
in CMR imaging served as controls.
TABLE 1 CMR Findings in the Study Population
Controls
(n ¼ 40)
Acute
Myocarditis
(n ¼ 61)
Convalescent
Myocarditis
(n ¼ 67) p Value
Functional parameters
LV-EDV index, ml/m2 74  12 94  35* 86  25 0.001
LV-ESV index, ml/m2 30  8 51  33* 41  25 0.001
LV mass index, ml/m2 50  14 70  21* 60  16 <0.001
LV ejection fraction, % 61  5 49  15* 55  11* <0.001
RV ejection fraction, % 57  8 53  13 57  10 0.12
Tissue characterization
Pericardial effusion 0 (0) 17 (28) 9 (13) 0.001
T2 edema ratio 1.3 (1.1–1.6) 2.3 (1.5–3.5)* 1.4 (1.1–2.3)† <0.001
Increased T2 SI 0 (0) 38 (62)* 8 (12)*† <0.001
Myocardium LGE
Present 0 (0) 51 (84) 59 (88) <0.001
Nonischemic pattern 0 (0) 51 (84) 59 (88) <0.001
Pericardial enhancement 0 (0) 18 (29)* 5 (7)*† <0.001
T1 mapping
Native T1, ms
1.5-T 940  20 1,064  37* 995  19*† <0.001
3.0-T 1,045  23 1,189  52* 1,099  22*† <0.001
Post-contrast T1, ms
1.5-T 422  68 373  42* 383  43* 0.03
3.0-T 442  68 397  62 426  73 0.06
Lambda, %
1.5-T 42  4 50  7* 46  9 0.005
3.0-T 44  5 53  8* 45  8† 0.002
Abnormal native T1, n (%) 0 (0) 60 (98)* 47 (76)* 0.001
Values are mean  SD, n (%), or median (range). *Signiﬁcant differences between patients with
myocarditis compared with control subjects. †Between the disease groups.
CMR ¼ cardiac magnetic resonance; EDV ¼ end-diastolic volume; ESV ¼ end-systolic volume;
LGE ¼ late gadolinium enhancement; LV ¼ left ventricular; RV ¼ right ventricular; SI ¼ signal
intensity.
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FIGURE 2 Comparison of Independent Cohorts for Native T1 Values
Native T1 values were increased in both acute and convalescent myocar
revealed signiﬁcantly higher native T1 in acute versus convalescent myo
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40Exclusion criteria for all subjects were the gener-
ally accepted contraindications to CMR (e.g., im-
plantable devices, cerebral aneurysm clips, cochlear
implants, severe claustrophobia) or a history of re-
nal disease with a current estimated glomerular
ﬁltration rate <30 ml/min/1.73 m2. The study protocol
was reviewed and approved by institutional ethics
committees, and written informed consent was ob-
tained from all participants.
CARDIAC MAGNETIC RESONANCE. All subjects un-
derwent a routine clinical protocol for volumes and
mass and tissue characterization with T2-weighted
imaging and LGE using 1.5- or 3.0-T CMR imaging
scanners equipped with advanced cardiac package
and multitransmit technology (Achieva, Philips
Healthcare, Best, the Netherlands) (12). T1 mapping
was performed in a single mid-ventricular short-
axis slice before contrast administration and scar
imaging, respectively (22–24). All routine CMR ana-
lyses were performed on commercially available
software (Circle CVI 42, Calgary, Canada). T1 mea-
surements and indexes were obtained as reported
previously (22–25). Details of CMR sequence parame-
ters and image post-processing are included in the
Online Appendix.
STATISTICAL ANALYSIS. Statistical analysis was
performed using SPSS software (version 21.0, SPSS,
Chicago, Illinois). Normality of distributions was
tested with the Kolmogorov-Smirnov statistic. Cate-
gorical data are expressed as percentages and1,100.0
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FIGURE 3 Reconstructed Time Course of Native T1 Values as a Function of
Time Since Onset of Symptoms
Comparison of independent patients in study cohort with a cohort of patients with
serial scans. The ﬁtting lines are approximate and for illustration only.
TABLE 2 Diagnostic Accuracy of CMR Parameters Using a Single or
Combined Approach: Acute Myocarditis
Sensitivity,
%
Speciﬁcity,
%
Diagnostic
Accuracy, %
PPV,
%
NPV,
% AUC p Value
Single approach
Increased T2 signal 56 94 70 95 55 0.751 <0.001
LGE 72 100 86 100 79 0.892 <0.001
Native T1 98 100 99 100 99 1.000 <0.001
Combined approach
T2 and LGE 54 100 68 100 48 0.742 <0.001
Native T1 and LGE 73 100 87 100 79 0.894 <0.001
Native T1 and T2
and LGE
54 100 68 100 48 0.742 <0.001
Diagnostic accuracy of CMR parameters for discrimination between control subjects and acute myocarditis using
native T1 as a categorical variable, on the basis of a predeﬁned cutoff value ($2 SD higher than the mean in the
healthy subjects): 992 ms at 1.5-T and 1,098 ms at 3.0-T, respectively (27). The diagnostic accuracy of several
combinations of tissue criteria (2 or 3 criteria positive): LGE þ T2-weighted imaging versus LGE þ T2-weighted
imaging þ native T1 for all myocarditis and acute and convalescent myocarditis separately.
AUC ¼ area under the curve; other abbreviations as in Table 1.
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41continuous variables as mean  SD or median (inter-
quartile range), as appropriate. For comparison of
2 and more than 2 normally distributed variables,
Student t test, 1-way analysis of variance (with Bon-
ferroni post-hoc test) for continuous variables and
chi-square test for categorical variables were used, as
appropriate. Correlations were assessed using Pear-
son correlation coefﬁcient for normally distributed
variables and Spearman correlation coefﬁcient for
nonparametric data. Associations were explored by
single and multivariate linear regressions. Binary
logistic regression analyses were used to test for
discrimination between the presence or absence of
myocarditis, as well as between acute disease and
chronic convalescence. Cutoff values for separate
ﬁeld strengths were deﬁned on the basis of the
previously derived normal ranges for native T1 as
2 SD higher than the mean (1.5-T: 950  21 ms;
3.0-T: 1,052  23 ms; i.e., 992 ms at 1.5-T and
1,098 ms at 3.0-T, respectively) (26). All tests were
2 tailed and a p value of <0.05 was considered
signiﬁcant.
RESULTS
Patients with acute myocarditis underwent CMR
study within a median of 5 days (range 7 days),
whereas patients in the convalescent group presented
on average 6 months (range 2 months) after onset
of the symptoms. Detailed clinical characteristics
of the study cohort are included in the Online
Appendix.
Compared with control patients, patients with
acute myocarditis had signiﬁcantly raised cardiac
volumes and mass (p < 0.01 for all) (Table 1). Global
systolic function was signiﬁcantly reduced in both
patient groups (p < 0.01). Groups were similar com-
pared between ﬁeld strengths (1.5-T vs. 3.0-T: control
patients n ¼ 18 vs. n ¼ 22; acute myocarditis n ¼ 23 vs.
n ¼ 38; convalescent myocarditis n ¼ 33 vs. n ¼ 34;
p > 0.05).
In the acute myocarditis group, patients exhibited
visually detectable increases in T2 signal and had a
high T2 edema ratio (Table 1). Myocardial LGE in the
epicardial and mid-myocardial nonischemic pattern
of distribution was present in 84% of patients
with acute myocarditis and 88% of patients with
convalescent myocarditis, respectively (p ¼ 0.36).
None of the patients showed ischemic-type LGE.
A total of 22 patients, 10 in the acute stage and 12
in the convalescent stage showed no LGE or in-
creased T2 SI.
Native T1 values were increased in patients at both
ﬁeld strengths (F ¼ 66 and F ¼ 119 for 1.5-T and 3.0-T,respectively; p < 0.001) (Table 1). Native T1 was
signiﬁcantly higher in acute myocarditis compared
with convalescent myocarditis at both ﬁeld strengths
(p < 0.001) (Figure 2). Compared with controls,
lambda was signiﬁcantly higher in acute myocarditis
(p < 0.01). In convalescent myocarditis, lambda was
not signiﬁcantly different than that in controls.
Native T1 values were signiﬁcantly higher in
patients with LGE and increased T2 SI (p < 0.001
for both) in acute myocarditis. In convalescent
TABLE 3 Diagnostic Accuracy of CMR Parameters Using a Single or
Combined Approach: Convalescent Myocarditis
Sensitivity,
%
Speciﬁcity,
%
Diagnostic
Accuracy, %
PPV,
%
NPV,
% AUC p Value
Single approach
Increased T2 signal 12 100 43 100 38 0.543 0.46
LGE 86 100 94 100 84 0.917 <0.001
Native T1 76 100 84 100 83 0.84 <0.001
Combined approach
T2 and LGE 76 100 89 100 84 0.922 <0.001
Native T1 and/or LGE 95 100 98 100 97 0.987 <0.001
Native T1 and LGE 62 100 79 100 67 0.838 <0.001
Native T1 and T2
and LGE
63 100 80 100 70 0.851 <0.001
Diagnostic accuracy of CMR parameters for discrimination between control subjects and convalescent myocarditis
using native T1 as a categorical variable, on the basis of a predeﬁned cutoff value ($2 SD higher than the mean
in the healthy subjects): 1,000 ms at 1.5-T and 1,106 ms at 3.0-T, respectively (27). The diagnostic accuracy
of several combinations of tissue criteria (2 or 3 criteria positive): LGE þ T2-weighted imaging versus LGE þ
T2-weighted imaging þ native T1 for all myocarditis and acute and convalescent myocarditis separately.
AUC ¼ area under the curve; other abbreviations as in Table 1.
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42myocarditis, native T1 values were increased in the
areas of LGE (native T1; neighboring LGE-negative
segments vs. LGE-positive segments, mean differ-
ence: 1.5-T 82  19 ms, p < 0.01; 3.0-T 102  18 ms,
p < 0.01).All Myocarditis
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in Figure 1.Details for the independent testing cohorts of
patients are included in the Online Appendix. Thirty-
seven patients presenting for CMR at the onset of
symptoms (median 3 days, range 7 days) underwent
a follow-up study (median 6 months, range 163 days).
Of these, 19 patients showed increased T2 SI at initial
presentation, whereas 22 had present LGE. Com-
pared with patients with acute myocarditis, native T1
values were signiﬁcantly lower in the follow-up scan
but still higher compared with those of control
patients (Online Appendix). Figure 3 reveals a gra-
dual decline of native T1 values over the course of
1 year as a function of time since the onset of
symptoms. Native T1 and lambda of the acute and
convalescent groups were not different than values in
the respective stages in the cohort with serial scans.
DISCRIMINATION BETWEEN HEALTH AND DISEASE
AND STAGES OF DISEASE. Binary logistic regression
revealed that native T1 is an independent discrimi-
nator between control subjects and patients with
myocarditis, as well as between patients with acute
myocarditis and convalescent myocarditis at both
ﬁeld strengths (Online Appendix). Tables 2 and 3
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FIGURE 5 Discrimination Between Acute and Convalescent
Myocarditis Using Native T1, T2-Weighted, and LGE Imaging
With pre-deﬁned cutoff values for normal ranges, acute
myocarditis can be independently identiﬁed by native T1 of >5
SD higher than the mean of the normal range, whereas conva-
lescence is best deﬁned by either abnormal native T1 (>2 SD)
or presence of LGE. Abbreviation as in Figure 1.
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43CMR using a single or combined approach (native T1,
T2, LGE) to detect acute myocarditis or convalescent
myocarditis, respectively. To simplify the compari-
sons with T2 and LGE being categorical values
(present/absent), which are ﬁeld strength indepen-
dent, native T1 was also transformed into a binary
categorical variable (normal/abnormal) on the basis of
the predeﬁned cutoff value of 2 SD higher than the
mean of the normal range per given ﬁeld strength
(26). Native T1 was able to discriminate between
health and disease in all patients with a clinical
diagnosis of myocarditis (Figure 4A), as well as its
separate disease stages (Figures 4B and 4C) with high
negative predictive value (NPV). In the acute setting,
abnormal native T1 alone resulted in the highest
diagnostic accuracy. In fact, diagnostic accuracy of
native T1 was reduced when it was used in a com-
bined approach requiring both positive LGE and
abnormal native T1. On the contrary, in the conva-
lescent stage, a native T1 and/or LGE approach held
the highest diagnostic accuracy. The addition of
increased T2 SI to any of the combined approaches
did not improve the diagnostic accuracy.
NOVEL DIAGNOSTIC ALGORITHM AND PROSPECTIVE
TESTING IN AN INDEPENDENT COHORT. We devel-
oped a novel diagnostic algorithm (native T1 of >5 SDfor acute myocarditis, and native T1 >2 SD or LGE for
convalescent stage, higher than the mean of the
normal range per given ﬁeld strength) (26) (Figure 5).
This algorithm resulted in diagnostic accuracy of
96% for acute myocarditis (sensitivity 96% and
speciﬁcity 100%; positive predictive value [PPV]
100%; NPV 97%) with 4% misclassiﬁcation due to 1
patient not achieving native T1 of >5 SD. In conva-
lescent myocarditis, diagnostic accuracy was 97%
(sensitivity 93% and speciﬁcity 100%; PPV 100%; NPV
94%) with 3% misclassiﬁcation due to 2 patients not
achieving native T1 of >2 SD or having a positive LGE.
Prospective testing of this algorithm in an indepen-
dent cohort of patients fulﬁlling identical inclusion
criteria for groups of disease (n ¼ 52; acute myo-
carditis, n ¼ 24, convalescent myocarditis, n ¼ 28,
control subjects, n ¼ 30) achieved similar diagnostic
performance.
DISCUSSION
We demonstrated that native T1 values are signiﬁ-
cantly increased in patients with a clinical diagnosis
of myocarditis. We further showed that native T1
values were higher in acute myocarditis compared
with convalescent myocarditis. Our ﬁndings revealed
a steady decline in native T1 values from acute dis-
ease to chronic convalescence. We also demonstrated
that native T1 is an independent discriminator
between health and disease, as well as a discriminator
between acute and convalescent stages of the dis-
ease. Acute myocarditis can be independently iden-
tiﬁed by native T1 of >5 SD higher than the mean of
the normal range, whereas convalescence is best
deﬁned by either abnormal native T1 (>2 SD) or
presence of LGE.
The commonly nonspeciﬁc clinical symptoms and
limited time window of laboratory markers pose
a signiﬁcant difﬁculty in early identiﬁcation of
patients, and the symptomatic phase of disease can
be consumed in the collateral diagnostic workup.
Patients with acute myocarditis frequently travel
along the standardized management pathways of
acute coronary syndrome (27), whereby a ﬁnding of
unobstructed coronary arteries provides an indication
to myocarditis. CMR is thus commonly ordered late in
the diagnostic cascade (28,29). Increasingly, CMR
imaging contributes early diagnostic clarity, previ-
ously not thought possible without a formal tissue
diagnosis (6). Even though LLC provide a diagnostic
pathway, the individual components of the criteria
suffer from technical limitations. Early changes
observed during acute myocarditis, such as expan-
sion of intracellular compartments due to viral
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44replication, are difﬁcult to detect with LGE, which
speciﬁcally targets the extracellular space. Similarly,
appreciation of increased T2 SI relies on the regional
differences. Edema ratio is on the basis of relative
comparison of signal to skeletal muscle, which can be
also affected, thus resulting in a pseudo-normalized
value. Relative enhancement is technically limited
by low reproducibility and susceptibility to artifacts
(12). Contribution of relative enhancement to diag-
nostic accuracy of detecting myocarditis on the basis
of 2 relatively small studies (9,10) was subsequently
shown to be of little relevance; in a prospective study
applying LLC, the combination of T2 and/or LGE
resulted in a higher diagnostic accuracy and higher
NPV in comparison with an “any 2 of 3” approach (13).
As such, the Society for Cardiovascular Magnetic
Resonance recommendations classify relative
enhancement ratio as “optional” in the myocarditis
imaging protocol (30); therefore, it was not used in
the present study.
Our ﬁndings support previous reports showing that
imaging readouts reﬂect the phenotypical expression
of the complex pathophysiology and underlying
myocardial inﬂammation following viral infection
(1–6,17–19). Acute myocarditis is classically deﬁned by
widespread intracellular changes related to viral
replication, and an extracellular spill of debris within
days of viral infection, followed by an acute inﬂam-
matory response and autoimmune reactions. Conva-
lescence or healing is characterized by contained
disease with regional scarring or a chronic syndrome
of prolonged low-grade inﬂammation, both of which
can result in myocardial remodeling, leading to heart
failure. Commonly, however, there is a complete
resolution of changes (1,2). Consistent with previous
ﬁndings, LGE ﬁndings are similarly prevalent at the
acute presentation and convalescence (Figure 5), and
increased T2 signal is more common in patients with
acute myocarditis (8,9,18–20). We further demon-
strated that native and post-contrast T1 myocardial
values, as well as the hybrid derivatives, were
increased in patients with acute myocarditis
compared with control subjects at both ﬁeld
strengths. Our ﬁndings conﬁrm previous studies us-
ing T1 mapping in myocardial inﬂammation showing
the higher diagnostic performance of native T1
compared with conventional LGE and T2-weighted
imaging in patients with clinical diagnosis of
myocarditis (19–21) (Figure 4A). We further showed
that by a rigorous separation between the stages of
active inﬂammation and convalescence, native T1 can
provide an insightful phenotypical signature by
considerably higher values in acute disease
(Figure 4B), contrasting the much lower or even“normalized” values in convalescence (Figure 4C).
Native T1 is also the only T1 mapping index that can
differentiate between health and disease indepen-
dently of the disease stage. Both ﬁndings suggest that
native T1 approximates the myocardial pathology in
the presence of active myocarditis and subsequent
low-grade inﬂammatory involvement (1,2,20–22).
Owing to these new insights, we provide a new
concept whereby native T1 serves as a diagnostic
clinical application for conﬁrmation/exclusion of
myocarditis independently of the stage of disease.
We propose that acute myocarditis can be best
differentiated by the “markedly” increased native T1
values (>5 SD higher than normal range), which can
be separated from the “abnormal” native T1 (>2 SD
higher than normal range) (Figure 5).
The ﬁndings of the present study allow us to
indicate possible pathophysiological routes in the
chronic disease. A ﬁnding of an abnormal native
T1 is congruent with persisting low-grade inﬂam-
mation and ventricular remodeling. Next, a ﬁnding
of normal T1 and positive LGE suggests that the
initially diffuse and widespread disease process of
inﬂammation has turned into a contained process
marked by myocardial scarring. This pathway is
reﬂected in the lower diagnostic accuracy on the
basis of abnormal native T1 alone in convalescent
myocarditis (88%) (Tables 2 and 3); this is improved
by using a combined approach with LGE (94%).
Finally, a complete resolution of myocardial changes
may be reﬂected in the misclassiﬁcation rate of
6%. A combination of tools that target intracellular,
interstitial, and regional disease in a complementary
algorithm using abnormal native T1 and/or LGE may
be able to follow the pathophysiological complexity
and characterize the phenotype of the convalescent
myocardium.
Results of the present study suggest that native T1
mapping may offer a novel approach to detect and
grade myocardial inﬂammation, as well as potentially
allow the detection of patients at risk of developing
heart failure. A quantiﬁable measure of acute injury,
which is distinctively different in the convalescent
stage of disease, may be useful to determine the
disease stage when residual myocardial injury can be
objectively assessed and the ensuing prognosis
potentially anticipated. So far, a few studies have
attempted to clarify whether and what treatment
might reduce the severity of changes, as well as
potentially reduce the rate of remodeling as a sequela
to the viral myocarditis, with mixed results (1–4).
Improved characterization of the stages of disease
may help to support initiation of treatments that
target the underlying pathophysiology.
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45STUDY LIMITATIONS. Even though the majority of
the patients in the original cohort study underwent
CMR at a single time point, the separation between
the acute and convalescent group was tested against
an independent sample of patients with serial scans.
A higher rate of positive troponin may reﬂect a
referral bias for clinical CMR but also an inadvertent
inclusion of more severe cases. The novel diagnostic
algorithm has been prospectively tested in an inde-
pendent, predominantly external dataset, which was
acquired using identical imaging parameters and
setups, allowing the use of the uniﬁed normal ranges
of native T1 values. Currently, particular setups of
available T1 mapping methods are site and vendor
speciﬁc, and accuracy and precision of T1 measure-
ments may vary between CMR systems and se-
quences; therefore, for application of this diagnostic
algorithm, it is necessary for sites to have established
their own local normal ranges. Cross-correlation withbiopsy tissue samples would lend further support to
our ﬁndings.
CONCLUSIONS
We demonstrated that native T1 values can reliably
discriminate between health and disease, as well as
provide insight into the stage of disease in patients
with a clinical diagnosis of myocarditis. Native T1
values may emerge as a novel approach to monitor
inﬂammatory myocardial injuries as a dynamic index
of disease activity and progression.
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